Lakefront Biotherapeutics NV annual gross profit
2021
2022
2023
2024
2025
Lakefront Biotherapeutics NV Gross Profit Growth & History (LKFT)
Lakefront Biotherapeutics NV's gross profit was €1.08B for fiscal 2025.
View full Lakefront Biotherapeutics NV company overviewLakefront Biotherapeutics NV annual gross profit history
| Fiscal year | Period ended | Gross profit | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | €1.08B | €841.7M | +349.57% |
| 2024 | 2024-12-31 | €240.8M | €1.1M | +0.44% |
| 2023 | 2023-12-31 | €239.7M | €10.6M | +4.61% |
| 2022 | 2022-12-31 | €229.2M | −€3.6M | −1.54% |
| 2021 | 2021-12-31 | €232.8M | — | — |
Lakefront Biotherapeutics NV gross profit trends
Between the periods ended 2021-12-31 and 2025-12-31, Lakefront Biotherapeutics NV's gross profit increased from €232.8M to €1.08B, a change of €849.8M.
About the metric
What gross profit means
Gross profit is the amount of revenue remaining after the direct costs of producing and delivering a company’s goods or services. It helps show the dollars available to cover operating expenses before operating income, interest, and taxes.
Calculation and source
SEC-reported and calculated gross profit
TickerStat uses gross profit reported in company SEC filings when available. Otherwise, it calculates gross profit as SEC-reported revenue minus aligned cost of revenue for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lakefront Biotherapeutics NV source filings ↗